Phase II study of 5?-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma
- 1 January 1986
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 16 (1), 78-79
- https://doi.org/10.1007/bf00255292
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neckEuropean Journal of Cancer and Clinical Oncology, 1984
- Phase II study of doxifluridine in advanced colorectal adenocarcinoma.Journal of Clinical Oncology, 1983
- Kinetics and metabolism of a new fluoropyrimidine, 5'-deoxy-5-fluorouridine, in humans.1983
- HIGH URIDINE PHOSPHORYLASE-ACTIVITY IN HUMAN-MELANOMA TUMOR1983
- PHASE-I CLINICAL-STUDY WITH 5'-DEOXY-5-FLUOROURIDINE, A NEW FLUOROPYRIMIDINE DERIVATIVE1982
- SELECTIVE ACTIVATION OF 5'-DEOXY-5-FLUOROURIDINE BY TUMOR-CELLS AS A BASIS FOR AN IMPROVED THERAPEUTIC INDEX1981
- Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridineEuropean Journal of Cancer (1965), 1980
- METABOLISM AND BIOLOGICAL-ACTIVITY OF 5'-DEOXY-5-FLUOROURIDINE, A NOVEL FLUOROPYRIMIDINE1980
- 5'-DFUR, A NEW ANTI-CANCER AGENT SELECTIVELY ACTIVATED IN TUMOR-CELLS .1. ROLE OF URIDINE PHOSPHORYLASE FOR ANTI-TUMOR ACTIVITY OF 5'-DEOXY-5-FLUOROURIDINE1980